Bertrand Loy's Net Worth

Bertrand Loy's net worth is estimated to be at least $85,503,082.84 as of 05/19/2024. CoreStreet's estimation of Bertrand Loy's net worth is based on their sale of stock and current holding of stock.

Bertrand Loy is Director at Harvard Bioscience Inc. They have executed at least 18 trades of stock as per SEC Form 4 filings. Their most recent trade was for 9,291 units of HBIO stock on 08/26/2022. Their biggest sale was on 04/05/2021 when they sold 300,444 units of Entegris Inc stock for $36,260,586.36. They typically trade 3 times per year.

Total value of insider buys:
  • $242,730.32
Total value of insider sells:
  • $85,260,352.52
Most recent insider trade:
  • Aug. 26, 2022

Bertrand Loy's Insider Trading History

Harvard Bioscience IncTitleAmountPriceTypeTotal Value
Aug. 26, 2022
Director9,291$3.41Buy$31,682.31
Aug. 24, 2022
Director17,291$3.23Buy$55,849.93
Aug. 22, 2022
Director4,918$3.16Buy$15,540.88
Aug. 18, 2022
Director1,151$3.19Buy$3,671.69
Nov. 13, 2019
Director6,100$2.52Buy$15,372.00
Nov. 11, 2019
Director12,855$2.59Buy$33,294.45
Nov. 8, 2019
Director6,616$2.64Buy$17,466.24
Sept. 13, 2019
Director7,372$3.11Buy$22,926.92
Sept. 11, 2019
Director15,590$3.01Buy$46,925.90
Entegris IncTitleAmountPriceTypeTotal Value
Aug. 11, 2021
CEO23,710$116.66Sell$2,766,008.60
Aug. 4, 2021
CEO17,000$125.42Sell$2,132,140.00
April 14, 2021
CEO100,000$118.43Sell$11,843,000.00
April 12, 2021
CEO100,000$119.36Sell$11,936,000.00
April 5, 2021
CEO300,444$120.69Sell$36,260,586.36
July 31, 2020
CEO118,520$71.80Sell$8,509,736.00
July 27, 2020
CEO75,943$69.64Sell$5,288,670.52
Feb. 22, 2018
CEO175,000$33.48Sell$5,859,000.00
Feb. 19, 2015
CEO49,348$13.48Sell$665,211.04